Nagase Hideaki, Fushimi Kazunari
Matrix Biology Department, Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College London, London, United Kingdom.
Connect Tissue Res. 2008;49(3):169-74. doi: 10.1080/03008200802151698.
Metalloproteinases that degrade extracellular matrix molecules play important roles in development and progression of various diseases. Among them, collagenases are unique as they have an ability to degrade triple helical interstitial collagens into 3/4 and 1/4 fragments, a crucial step for collagenolysis in the tissue. Collagenases, consisting of a catalytic domain and a hemopexin domain, requires both domains for collagenolysis. The enzymes unwind triple helical collagen before they hydrolyze the peptide bonds. Aggrecanases are also multidomain metalloproteinases belonging to the ADAMTS family, and the noncatalytic ancillary domains also play an important role in recognition of aggrecan and their activities. Attenuation of collagenase and aggrecanase activities will be achieved by inhibitors or antibodies that interact directly with those noncatalytic ancillary domains (exosite inhibitors). Such molecules will be attractive for therapy as they will be highly selective because they are based on the unique mechanism of each proteinase.
降解细胞外基质分子的金属蛋白酶在各种疾病的发生和发展中起着重要作用。其中,胶原酶独具特色,因为它们能够将三股螺旋的间质胶原降解为3/4和1/4片段,这是组织中胶原分解的关键步骤。胶原酶由一个催化结构域和一个血红素结合蛋白结构域组成,胶原分解需要这两个结构域。这些酶在水解肽键之前先解开三股螺旋的胶原。聚集蛋白聚糖酶也是属于ADAMTS家族的多结构域金属蛋白酶,非催化辅助结构域在聚集蛋白聚糖的识别及其活性中也起着重要作用。通过与那些非催化辅助结构域直接相互作用的抑制剂或抗体(外位点抑制剂)可以实现胶原酶和聚集蛋白聚糖酶活性的减弱。这类分子将因其高度选择性而对治疗具有吸引力,因为它们基于每种蛋白酶的独特作用机制。